MometaHEXAL Heuschnupfenspray clinical trials

Phase II-III study to assess efficacy and safety of sublingual immunotherapy in patients suffering from grass pollen allergy

This study is looking at a new way to treat grass pollen allergy using a spray under the tongue. It wants to see if this `sublingual immunotherapy` can reduce hay fever symptoms and the need for other medicines, making life better for people with moderate to severe grass pollen allergies.